Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium clorazepate poisoning of undetermined intent |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium clorazepate adverse reaction |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium clorazepate allergy |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental potassium clorazepate overdose |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dipotassium clorazepate 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorazepate dipotassium 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dipotassium clorazepate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dipotassium clorazepate 11.25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorazepate dipotassium 7.5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clorazepate dipotassium 3.75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clorazepate dipotassium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional potassium clorazepate poisoning |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Potassium clorazepate allergy |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chlorazepate dipotassium measurement |
Component |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 15 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 15 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clorazepate dipotassium 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clorazepate dipotassium 7.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 15 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dipotassium clorazepate 11.25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dipotassium clorazepate 11.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clorazepate dipotassium 3.75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clorazepate dipotassium 3.75 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 7.5 mg oral capsule |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 15 mg oral capsule |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dipotassium clorazepate 22.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clorazepate dipotassium 7.5 mg oral tablet |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dipotassium clorazepate 15 mg oral tablet |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dipotassium clorazepate 11.25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clorazepate dipotassium 3.75 mg oral tablet |
Has precise active ingredient |
True |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to dipotassium clorazepate |
Causative agent (attribute) |
False |
Dipotassium clorazepate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |